Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

waters corp. - WAT

WAT

Close Chg Chg %
383.17 1.74 0.45%

Closed Market

384.91

+1.74 (0.45%)

Volume: 116.07K

Last Updated:

Dec 24, 2025, 12:59 PM EDT

Trade Now

Company Overview: waters corp. - WAT

WAT Key Data

Open

$383.83

 Day Range

381.06 - 385.58

52 Week Range

275.05 - 423.56

 Market Cap

$22.82B

Shares Outstanding

59.55M

 Public Float

59.47M

Beta

1.16

 Rev. Per Employee

N/A

P/E Ratio

35.38

 EPS

$10.91

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

569.77K

  

WAT Performance

1 Week
 
 1.80%
 
1 Month
 
 -4.61%
 
3 Months
 
 31.92%
 
1 Year
 
 2.73%
 
5 Years
 
 55.74%
 

WAT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 20
Full Ratings ➔

About waters corp. - WAT

Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and services. The TA segment products and services include thermal analysis, rheometry and calorimetry instrument systems, and service sales. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.

WAT At a Glance

Waters Corp.
34 Maple Street
Milford, Massachusetts 01757
Phone 1-508-478-2000 Revenue 2.96B
Industry Medical Specialties Net Income 637.83M
Sector Health Technology 2024 Sales Growth 0.067%
Fiscal Year-end 12 / 2025 Employees 7,600
View SEC Filings

WAT Valuation

P/E Current 35.383
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 34.637
Price to Sales Ratio 7.468
Price to Book Ratio 12.049
Price to Cash Flow Ratio 28.99
Enterprise Value to EBITDA 22.488
Enterprise Value to Sales 7.933
Total Debt to Enterprise Value 0.073

WAT Efficiency

Revenue/Employee 389,261.447
Income Per Employee 83,925.526
Receivables Turnover 4.034
Total Asset Turnover 0.644

WAT Liquidity

Current Ratio 2.113
Quick Ratio 1.509
Cash Ratio 0.412

WAT Profitability

Gross Margin 57.802
Operating Margin 28.794
Pretax Margin 25.516
Net Margin 21.56
Return on Assets 13.895
Return on Equity 42.824
Return on Total Capital 18.065
Return on Invested Capital 18.172

WAT Capital Structure

Total Debt to Total Equity 93.10
Total Debt to Total Capital 48.213
Total Debt to Total Assets 37.383
Long-Term Debt to Equity 91.704
Long-Term Debt to Total Capital 47.49
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Waters Corp. - WAT

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
2.79B 2.97B 2.96B 2.96B
Sales Growth
+17.78% +6.68% -0.52% +0.07%
Cost of Goods Sold (COGS) incl D&A
1.16B 1.25B 1.23B 1.25B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
131.68M 130.42M 165.91M 191.82M
Depreciation
71.56M 72.00M 84.63M 87.02M
Amortization of Intangibles
60.12M 58.42M 81.28M 104.81M
COGS Growth
+13.82% +7.68% -1.81% +1.67%
Gross Income
1.62B 1.72B 1.73B 1.71B
Gross Income Growth
+20.78% +5.97% +0.41% -1.07%
Gross Profit Margin
+58.31% +57.92% +58.47% +57.80%
2021 2022 2023 2024 5-year trend
SG&A Expense
795.33M 834.22M 884.96M 858.17M
Research & Development
168.36M 176.19M 174.94M 183.03M
Other SG&A
626.97M 658.03M 710.01M 675.15M
SGA Growth
+19.15% +4.89% +6.08% -3.03%
Other Operating Expense
- - - -
-
Unusual Expense
(4.49M) 15.97M 26.16M 26.32M
EBIT after Unusual Expense
833.68M 871.25M 817.45M 825.50M
Non Operating Income/Expense
17.45M 15.39M 17.65M 19.04M
Non-Operating Interest Income
12.22M 11.02M 16.62M 17.42M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
44.94M 48.80M 98.86M 89.68M
Interest Expense Growth
-8.42% +8.59% +102.60% -9.29%
Gross Interest Expense
44.94M 48.80M 98.86M 89.68M
Interest Capitalized
- - - -
-
Pretax Income
806.19M 837.85M 736.24M 754.87M
Pretax Income Growth
+31.97% +3.93% -12.13% +2.53%
Pretax Margin
+28.94% +28.19% +24.90% +25.52%
Income Tax
113.35M 130.09M 94.01M 117.03M
Income Tax - Current - Domestic
19.99M 70.18M 6.61M 27.00M
Income Tax - Current - Foreign
76.72M 91.90M 88.60M 90.91M
Income Tax - Deferred - Domestic
10.84M (30.97M) (5.49M) (80.00K)
Income Tax - Deferred - Foreign
5.80M (1.02M) 4.29M (797.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
692.84M 707.75M 642.23M 637.83M
Minority Interest Expense
- - - -
-
Net Income
692.84M 707.75M 642.23M 637.83M
Net Income Growth
+32.84% +2.15% -9.26% -0.69%
Net Margin Growth
+24.87% +23.81% +21.72% +21.56%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
692.84M 707.75M 642.23M 637.83M
Preferred Dividends
- - - -
-
Net Income Available to Common
692.84M 707.75M 642.23M 637.83M
EPS (Basic)
11.252 11.7989 10.8713 10.7501
EPS (Basic) Growth
+33.96% +4.86% -7.86% -1.11%
Basic Shares Outstanding
61.58M 59.98M 59.08M 59.33M
EPS (Diluted)
11.1698 11.7312 10.8357 10.7105
EPS (Diluted) Growth
+33.66% +5.03% -7.63% -1.16%
Diluted Shares Outstanding
62.03M 60.33M 59.27M 59.55M
EBITDA
960.87M 1.02B 1.01B 1.04B
EBITDA Growth
+19.68% +5.91% -0.80% +3.38%
EBITDA Margin
+34.49% +34.24% +34.15% +35.28%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 415.40
Number of Ratings 20 Current Quarters Estimate 4.516
FY Report Date 12 / 2025 Current Year's Estimate 13.116
Last Quarter’s Earnings 3.40 Median PE on CY Estimate N/A
Year Ago Earnings 11.86 Next Fiscal Year Estimate 14.245
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 14 17 17
Mean Estimate 4.52 2.51 13.12 14.25
High Estimates 4.57 2.61 13.17 14.52
Low Estimate 4.45 2.42 13.05 13.54
Coefficient of Variance 0.64 2.34 0.21 1.57

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 6 5 4
OVERWEIGHT 2 2 3
HOLD 10 10 11
UNDERWEIGHT 2 2 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Waters Corp. - WAT

Date Name Shares Transaction Value
Apr 9, 2025 Jianqing Y. Bennett SVP TA Instruments Division 4,916 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $325.8 per share 1,601,632.80
Jan 7, 2025 Flemming Ørnskov Director 818 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Wei Jiang Director 818 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Wei Jiang Director 2,357 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Heather Knight Director 818 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Heather Knight Director 560 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Pearl Shirley Huang Director 818 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Pearl Shirley Huang Director 2,946 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Daniel J. Brennan Director 818 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Daniel J. Brennan Director 1,025 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Linda Baddour Director 2,569 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Flemming Ørnskov Director 4,628 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Mark P. Vergnano Director 818 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Mark P. Vergnano Director 4,210 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Christopher A. Kuebler Director 818 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Christopher A. Kuebler Director 15,035 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Richard H. Fearon Director 818 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Richard H. Fearon Director 1,972 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2025 Linda Baddour Director 818 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Waters Corp. in the News